English Session
Monday, April 25
- S4: Advances on osteoarthritis pathogenesis and treatment
- EL7: Transforming clinical trials in rheumatology: towards patient-centric precision medicine
- S5: Rapidly changing paradigm of vasculitis treatment
- S6: Recent advances in macrophage and osteoclast research in rheumatoid arthritis
- S7: Multi-layer omics research of human immunology
Tuesday, April 26
Wednesday, April 27
- S17: A multifaceted approach to the treatment of autoimmune diseases
- EL18: Functional MRI in rheumatoid arthritis: an ideal translational tool for basic research and prediction of therapeutic outcome in the clinics
- EL24: Wnt signaling in bone homeostasis and disease: Sclerostin Biology and Inhibition
- S18: Precision medicine in rheumatic diseases
Symposium (Held onsite, Live and On-demand streaming)
S4
Advances on osteoarthritis pathogenesis and treatment
Monday, April 25 9:30-12:00 4F Room 10 (G401+G402)
- Chairs:
-
Hiroshi Takayanagi
Department of Immunology Graduate School of Medicine and Faculty of Medicine The University of Tokyo, Japan
-
Taku Saito
Orthopaedic Surgery, Graduate School of Medicine, The University of Tokyo, Japan
- S4-1
- Epidemiology and treatment of osteoarthritis
-
David J. Hunter
Kolling Institute, University of Sydney, Sydney, Australia
- S4-2
- Mechanisms of synovial joint development, maintenance, and degeneration
-
Taku Saito
Orthopaedic Surgery, Graduate School of Medicine, The University of Tokyo, Japan
- S4-3
- Application of iPS cell-derived cartilage to regenerate articular cartilage damage
-
Noriyuki Tsumaki
Department of Biochemistry and Molecular Biology, Graduate School of Medicine, Osaka University, Japan
- S4-4
- Join pain in osteoarthritis
-
Xu Cao
Johns Hopkins University, USA
- S4-5
- Efficacy of anti-NGF antibody in osteoarthritis
-
Marc Hochberg
University of Maryland School of Medicine, Baltimore, USA
S5
Rapidly changing paradigm of vasculitis treatment
Monday, April 25 14:50-16:50 1F Room 1 (G1+G2)
- Chairs:
-
Masayoshi Harigai
Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine, Japan
-
Tomonori Ishii
Clinical Reserch, Education and Innovation Center, Tohoku University Hospital, Japan
- S5-1
- SARS-CoV-2-associated vasculopathy and vasculitis - an enigmatic disease
-
Akihiro Ishizu
Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan
- S5-2
- Useful biomarkers in the management of vasculitides
-
Jun Ishizaki
Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan
- S5-3
- Emerging molecular targeted therapy of microscopic polyangiitis and granulomatosis with polyangiitis - when, which and how to use?
-
Masayoshi Harigai
Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Japan
- S5-4
- Optimizing treatment of large vessel vasculitides-the time is now
-
Takahiko Sugihara
Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, Japan
S6
Recent advances in macrophage and osteoclast research in rheumatoid arthritis
Monday, April 25 14:50-16:50 3F room 4(G301+G302)
- Chairs:
-
Hiroshi Takayanagi
Department of Immunology Graduate School of Medicine and Faculty of Medicine The University of Tokyo, Japan
-
Takeshi Miyamoto
Department of Orthopedic Surgery, Kumamoto University, Japan
- S6-2
- Resident synovial macrophages as gate-keepers of joint inflammation
-
Gerhard Krönke
University of Erlangen, Germany
- S6-4
- Synovial tissue macrophages in joint homeostasis, Rheumatoid Arthritis, and disease remission
-
Mariola Kurowska-Stolarska
Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), University of Glasgow, UK
S7
Multi-layer omics research of human immunology
Monday, April 25 14:50-16:50 4F room 10 (G401+G402)
- Chairs:
-
Yukinori Okada
Department of Statistical Genetics, Osaka University Graduate School of Medicine, Japan / Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Japan
-
Hisashi Arase
Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Japan
- S7-1
- Interpreting immune disease GWAS signals with single cell transcriptomics from immune cells
-
Gosia Trynka
Wellcome Sanger Institute, UK
- S7-2
- Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases
-
Ilya Korsunsky
Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA / Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA / Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA / Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA / Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- S7-3
- Novel function of MHC molecules in the pathogenesis of autoimmune diseases
-
Hisashi Arase
Laboratory of Immunochemistry, Immunology Frontier Research Center, Osaka University, Japan / Department of Immunochemistry, Research Institute for Microbial Diseases, Japan
- S7-4
- Genetics of rheumatoid-associated interstitial lung disease
-
Philippe Dieude
Université de Paris, INSERM UMR 1152, Paris, France / Service de Rhumatologie, Hôpital Bichat-Claude Bernard, AP-HP, F-75018, Paris, France
- S7-5
- Microbiome analysis of autoimmune diseases
-
Yukinori Okada
Department of Statistical Genetics, Osaka University Graduate School of Medicine, Japan / Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Japan
S17
A multifaceted approach to the treatment of autoimmune diseases
Wednesday, April 27 8:30-11:00 4F Room 10 (G401+G402)
- Chairs:
-
Kunihiro Yamaoka
Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan
-
Jon T. Giles
Columbia University, College of Physicians & Surgeons, USA
- S17-1
- Advanced understanding of the pathophysiology of Spondyloarthropathy
-
Georg A. Schett
FAU Erlangen Nürnberg, Germany
- S17-2
- What should we aim for in treatment of SLE?
-
Eric Morand
Monash University, Melbourne, Australia
- S17-3
- Managing Rheumatoid Arthritis: Now and the Future
-
Jon T. Giles
Columbia University, College of Physicians & Surgeons, USA
- S17-4
- COVID-19 in autoimmune inflammatory rheumatic diseases
-
Jeffrey A. Sparks
Brigham and Women's Hospital, Harvard Medical School, USA
- S17-5
- Treatment of interstitial lung disease in autoimmune diseases
-
Masataka Kuwana
Department of Allergy and Rheumatology, Nippon Medical School, Japan
S18
Precision medicine in rheumatic diseases
Wednesday, April 27 14:40-17:10 1F Room 1 (G1+G2)
- Chairs:
-
Tsutomu Takeuchi
Saitama Medical University, Japan / Keio University, Japan
-
Yoshiya Tanaka
The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan
- S18-1
- Genomics-driven approaches for personalized medicine
-
Yukinori Okada
Department of Statistical Genetics, Osaka University Graduate School of Medicine, Japan / Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences, Japan
- S18-2
- Pathobiological Approaches to Precision Medicine
-
John D. Isaacs
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
- S18-3
- Precision medicine using immunophenotypic analysis
-
Shingo Nakayamada
First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
- S18-4
- Precision medicine by multiomics analysis
-
Katsuya Suzuki
Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Japan
- S18-5
- Future perspectives on precision medicine in rheumatic diseases
-
Daniel Aletaha
Division of Rheumatology, Medical University Vienna, Austria
Special Symposium (Held onsite, Live and On-demand streaming)
SS2 (ACR Session)
Translational Research Programs to Define Mechanisms of Complex Inflammatory Diseases
Tuesday, April 26 8:30-10:30 4F Room 10(G401+G402)
- Chairs:
-
Yoshiya Tanaka
The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan
-
Kazuhiko Yamamoto
Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Japan
- SS2-1
- When normal isn't normal: understanding the skin in systemic lupus
-
J. Michelle Kahlenberg
Department of Internal Medicine, Rheumatology, University of Michigan, Ann Arbor, Michigan, USA
- SS2-2
- Somatic Mutations in Rheumatologic Diseases: VEXAS Syndrome and Beyond
-
Peter Grayson
National Institutes of Health, USA
SS3 (EULAR Session)
Innovations in Arthritis - New frontiers of Rheumatology?
Tuesday, April 26 14:10-16:10 4F Room 10(G401+G402)
- Chairs:
-
Tsutomu Takeuchi
Saitama Medical University, Japan / Keio University, Japan
-
Atsushi Kawakami
Nagasaki University Graduate School of Biomedical Sciences, Japan
- SS3-1
- Innovative Imaging in RA
-
Annamaria Iagnocco
Università degli Studi di Torino, Turin Italy
- SS3-2
- Innovative Imaging in PsA
-
Xenofon Baraliakos
Rheumazentrum Ruhrgebiet Herne / Ruhr-University Bochum, Germany
- SS3-3
- Precision medicine in RA
-
Daniel Aletaha
Division of Rheumatology, Medical University Vienna, Austria
- SS3-4
- Precision Medicine in Psoriatic Arthritis
-
Iain B. Mcinnes
University of Glasgow, UK
Educational Lecture (Held onsite and On-demand streaming)
EL7
Transforming clinical trials in rheumatology: towards patient-centric precision medicine
Monday, April 25 14:40-15:40 3F Room 5 (G303)
- Chair:
-
Mineto Ota
Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo, Japan
- Lecturer:
-
Costantino Pitzalis
Queen Mary University of London, UK
EL13
Why remission is not enough?
Tuesday, April 26 14:10-15:10 1F Room 2 (G7)
- Chair:
-
Yukinori Okada
Department of Statistical Genetics, Osaka University Graduate School of Medicine, Japan
- Lecturer:
-
Georg A. Schett
FAU Erlangen Nürnberg, Germany
EL18
Functional MRI in rheumatoid arthritis: an ideal translational tool for basic research and prediction of therapeutic outcome in the clinics
Wednesday, April 27 8:30-9:30 1F Room 2 (G7)
- Chair:
-
Kei Ikeda
Chiba University Hospital, Japan
- Lecturer:
-
Andreas Hess
I. f. Experimental Pharmacology, FAU Erlangen-Nürnberg, Germany
EL24
Wnt signaling in bone homeostasis and disease: Sclerostin Biology and Inhibition
Wednesday, April 27 13:50-14:50 3F Room 5 (G303)
- Chair:
-
Yuho Kadono
Orthopaedic Surgery, Saitama Medical University, Japan
- Lecturer:
-
Roland Baron
Department of Medicine, Harvard Medical School, Boston, USA / Department of Oral Medicine, Harvard School of Dental Medicine, USA